Skip to main content
Moira Aitken, MD, Pulmonology, Seattle, WA, UW Medicine/University of Washington Medical Center

MoiraLAitkenMD

Pulmonology • Seattle, WA

Pleural Disease

Professor, Medicine, University of Washington School of Medicine

Join to view full profile

Are you Dr. Aitken?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 29 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    University of Washington Medical Ctr
    1959 NE Pacific St
    Seattle, WA 98195
    Phone+1 206-598-4615
    Fax+1 206-598-6963
  • Is this information wrong?

Summary

  • Dr. Moira Aitken, MD is a pulmonologist in Seattle, Washington. She is currently licensed to practice medicine in Washington. She is affiliated with UW Medicine/University of Washington Medical Center and is a Professor at University of Washington School of Medicine.

Education & Training

  • University of Edinburg Medical School
    University of Edinburg Medical SchoolClass of 1978, MD

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1983 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • The Association Between Heroin Inhalation and Early Onset Emphysema
    The Association Between Heroin Inhalation and Early Onset EmphysemaJuly 17th, 2020
  • New Medication Effectively Treats Underlying Cause of Cystic Fibrosis in Some Patients, Study Shows
    New Medication Effectively Treats Underlying Cause of Cystic Fibrosis in Some Patients, Study ShowsNovember 3rd, 2011
  • Who Gets Early Tracheostomy?: Evidence of Unequal Treatment at 185 Academic Medical Centers
    Who Gets Early Tracheostomy?: Evidence of Unequal Treatment at 185 Academic Medical CentersFebruary 10th, 2016

Grant Support

  • A Phase IIA Safety And Efficacy Study Of Oral Spi-8811 In Patients With CFNational Center For Research Resources2005
  • Safety And Tolerability Study Of Theraclec-Total In Subjects With CFNational Center For Research Resources2004
  • Phase IIA Safety And Efficacy Study Of Oral Spi-8811National Center For Research Resources2004
  • Oral Multidose CPX In Adult PTS W/ Mild To Severe CFNational Center For Research Resources2000–2002
  • Efficacy, &Methodology Study In Atopic PTS W/ AsthmaNational Center For Research Resources2000–2002
  • Phase II Trial Of Oral Multidose CPX In Adult Patients W/ Mild To CFNational Center For Research Resources1999–2000
  • Multiple Oral Dose Safety, Efficacy, &Methodology Study In AtopicNational Center For Research Resources1999–2000
  • Phase I Trial Of CPX In Adults With Mild Cystic FibrosisNational Center For Research Resources1998–2000
  • Nontuberculous Mycobacteria In Patients With Cystic FibrosisNational Center For Research Resources1997–2000
  • Phase I Trial CPX In Adult Patients With Mild Cystic FibrosisNational Center For Research Resources1998–1999
  • Pilot Study--Aav For Gene Transfer And Expression In Rabbit Airway EpitheliumNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
  • Development Toward An In Vivo Model For CF Gene TherapyNational Heart, Lung, And Blood Institute1996–1999
  • Cellular Differentiation Of Airway EpitheliumNational Heart, Lung, And Blood Institute1987–1991

Hospital Affiliations

Dr. Moira Aitken, Dr. Moira Aitken, MD, Dr. M Aitken, Dr. Moira L Aitken